We are live on ! Find out more
DICE

DICE Therapeutics, Inc. Common Stock
DICE

Delisted

DICE was delisted on the 8th of August, 2023.

Back to rankings

0 hedge funds and large institutions have $0 invested in DICE Therapeutics, Inc. Common Stock in 2023 Q3 according to their latest regulatory filings, with 0 funds opening new positions, 0 increasing their positions, 0 reducing their positions, and 159 closing their positions.

New
Increased
Maintained
Reduced
Closed

100% less funds holding

Funds holding: 160 → 0 (-160)

100% less funds holding in top 10

Funds holding in top 10: 10 → 0 (-10)

100% less capital invested

Capital invested by funds: $2.11B → $0 (-$2.11B)

100% less first-time investments, than exits

New positions opened: 0 | Existing positions closed: 159

Holders
–
Holders Change
-160
Holders Change %
-100%
% of All Funds
–
Holding in Top 10
–
Holding in Top 10 Change
-10
Holding in Top 10 Change %
-100%
% of All Funds
–
New
–
Increased
–
Reduced
–
Closed
159
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

No buyers this quarter

Top Sellers

Rank Fund Capital Flow
1
RCM
RA Capital Management
Massachusetts
-$365M
2
BlackRock
BlackRock
New York
-$135M
3
Fidelity Investments
Fidelity Investments
Massachusetts
-$104M
4
ACA
Avoro Capital Advisors
New York
-$102M
5
AAM
Alpine Associates Management
Florida
-$98.3M
Name Holding Trade Value Shares
Change 		Change in
Stake
RCM
1
RA Capital Management
Massachusetts
– -$365M -7,856,612 Closed
BlackRock
2
BlackRock
New York
– -$135M -2,895,307 Closed
Fidelity Investments
3
Fidelity Investments
Massachusetts
– -$104M -2,239,223 Closed
ACA
4
Avoro Capital Advisors
New York
– -$102M -2,199,342 Closed
AAM
5
Alpine Associates Management
Florida
– -$98.3M -2,116,800 Closed
DCM
6
Driehaus Capital Management
Illinois
– -$94.7M -2,038,257 Closed
Vanguard Group
7
Vanguard Group
Pennsylvania
– -$90.9M -1,957,417 Closed
MF
8
Magnetar Financial
Illinois
– -$53.7M -1,155,887 Closed
PCM
9
Pentwater Capital Management
Florida
– -$50.2M -1,080,507 Closed
UOC
10
UBS O'Connor
Illinois
– -$49.9M -1,075,000 Closed
BBA
11
Baker Bros. Advisors
New York
– -$48.1M -1,035,786 Closed
B
12
Braidwell
Connecticut
– -$47.8M -1,029,901 Closed
WCMNY
13
Westchester Capital Management (New York)
New York
– -$45.5M -978,893 Closed
Balyasny Asset Management
14
Balyasny Asset Management
Illinois
– -$42.5M -913,940 Closed
KC
15
Kryger Capital
United Kingdom
– -$40.9M -880,756 Closed
State Street
16
State Street
Massachusetts
– -$38.8M -835,909 Closed
Geode Capital Management
17
Geode Capital Management
Massachusetts
– -$34.5M -743,341 Closed
NAM
18
Nexpoint Asset Management
Texas
– -$33.3M -717,322 Closed
Goldman Sachs
19
Goldman Sachs
New York
– -$32.8M -707,039 Closed
JP Morgan Chase
20
JP Morgan Chase
New York
– -$28.7M -618,089 Closed
Morgan Stanley
21
Morgan Stanley
New York
– -$27.9M -599,469 Closed
Millennium Management
22
Millennium Management
New York
– -$26M -560,358 Closed
AllianceBernstein
23
AllianceBernstein
Tennessee
– -$25.6M -551,647 Closed
WIC
24
Water Island Capital
New York
– -$22.5M -483,894 Closed
VI
25
Versor Investments
New York
– -$20.3M -436,935 Closed
1
2 3 4 5

DICE Hedge Fund Activity: Q3 2023 in Review

0 of the 6,301 institutional investors tracked by Wall St. Rank reported a position in DICE Therapeutics, Inc. Common Stock (DICE) for Q3 2023, worth a combined $0 — down 100% from $2.11B a quarter earlier.

Sellers outnumbered buyers: 159 funds closed out of DICE and 0 opened new positions — a net loss of 159 holders — while 0 trimmed existing stakes and 0 added.

The largest seller was RA Capital Management, exiting entirely with an estimated $365M sold.

  • 0 institutional investors held DICE Therapeutics, Inc. Common Stock (DICE) as of Q3 2023, down from 160 in Q2 2023.
  • Funds reported $0 of DICE Therapeutics, Inc. Common Stock stock for Q3 2023, down 100% quarter-over-quarter.
  • 0 funds opened new DICE Therapeutics, Inc. Common Stock positions in Q3 2023 and 159 closed out, a net change of -159 holders.
  • The largest DICE Therapeutics, Inc. Common Stock seller in Q3 2023 was RA Capital Management, an estimated $365M sold.

Based on aggregated 13F filings for Q3 2023.